RGIN
Healthcare BiotechnologyRegenicin, Inc.
$0.00
-0.00 -0.00% today
Price History
Not enough data
Key Stats
Market Cap
15,348.305
Avg Volume
0
EPS
-$0.01
52W High
$0.75
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
-0.00
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Assets
(9.4%)
Liquidity & Leverage
Current Ratio
0.66
Quick Ratio
0.66
Total Cash
11.86M
Total Debt
642,918
About
Regenicin, Inc. focuses on developing and commercializing the technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company's products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
www.regenicin.com